L’Oréal has devoted itself to beauty for over 100 years. With its unique international portfolio of diverse and complementary brands, the Group generated sales amounting to 26.9 billion euros in 2018 and employs 82 000 people worldwide.
Research & Innovation, and a dedicated research team of 3 993 people, are at the core of L’Oréal’s strategy, working to meet beauty aspirations all over the world. L’Oréal’s sustainability commitment for 2020 “Sharing Beauty With All” sets out ambitious sustainable development objectives across the Group’s value chain.
Consumer health and safety is and has always been an absolute priority of the L’Oréal Group. Defending animals’ welfare as well. To achieve these two objectives, L’Oréal conducts a very strict safety evaluation policy for its products. Starting by the development of the first models of reconstructed skins in 2019, L’Oréal has been a pioneer in the development and use of new alternative in vitro and in silico methods.
Thanks to this long term investment and conviction , L’Oréal stopped testing its products on animals in 1989, 14 years before required to do so by law. L’Oréal no longer tests its ingredients on animals neither tolerates any exceptions to this rule.
L’Oréal’s commitment to ending animal testing is supported by the provision of reconstructed skin models thanks to 3 production Units through its subsidiary EPISKIN SA (based in France, China, Brazil), the development and validation of new alternative methods and the sharing of its scientific advances.
In 2017, the OECD adopted two new alternatives methods developed by the L’Oréal Research Laboratories, to evaluate skin allergy and eye irritation. Today, L’Oréal is committed to develop next generation of new safety assessment approaches alternative to animal testing to ensure product safety for consumers and environment and support innovation.